Author

Daniel R. Getts

ORCID 0000-0002-5555-9659Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

Neha DiwanjiiD· 2 shared Bianca P. LavayeniD· 1 shared Bruce J. McCreedy· 1 shared Meghan T. HarrisiD· 1 shared Robert Hofmeister· 1 shared Ruei‐Zeng LiniD· 1 shared Yuxiao WangiD· 1 shared Yuxiao WangiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSynthetic Biology

Neha DiwanjiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Synthetic BiologyEMBO ReportsPeer-reviewedJan 9, 2025

CRISPR-Enabled Autonomous Transposable Element (CREATE) for RNA-based gene editing and delivery

Yuxiao Wang, Ruei‐Zeng Lin, Meghan T. Harris…·Daniel R. Getts

The paper introduces CREATE, an RNA-based gene editing system that delivers large genes without DSBs or DNA templates, achieving specific genomic integration in human cells.

15 citations

humanCRISPR screen

𝕏 PostBluesky

ImmunologyImmunoHorizonsPeer-reviewedJan 1, 2024

Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer Cells

Neha Diwanji, Daniel R. Getts, Yuxiao Wang

This paper develops an in-vivo method to engineer tumor-targeting NK cells using CARs that rely on NK receptor biology for specificity and function.

11 citations

humanproteomics

𝕏 PostBluesky